CytoReason

📍 Tel Aviv, Israel🗓 Founded 2016👥 131 employees💰 Last funded Sep 2024
Biotechnology Research🌐 cytoreason.com
Website LinkedIn
CytoReason is a tech company transforming biopharma’s decision-making from trial and error to data-driven using an AI Platform of computational disease models. With its extensive database of public and proprietary data, the company maps human diseases – tissue by tissue and cell by cell. Researchers of all levels rely on CytoReason’s technology to make data-driven decisions across the drug development life cycle. Scientists can identify potential targets, prioritize indications, and stratify patient populations. Program leaders can compare drugs across multiple diseases or multiple drugs within a single disease. C-level executives can gain valuable tools to manage and optimize entire drug portfolios.
2
Total investors
0
Early stage
1
Mid stage
1
Late stage
2016
Founded

Investors

2 investors
All
Early stage
Mid stage
Late stage
Investor geography2 countries
Israel
1
United Kingdom
1
Frequently asked questions
Who invested in CytoReason?
CytoReason has 2 investors on record on gritt.io, 1 mid-stage and 1 late-stage investors.
When did CytoReason last raise funding?
The most recent investment in CytoReason recorded on gritt.io was in September 2024.
When was CytoReason founded?
CytoReason was founded in 2016.
What industry is CytoReason in?
CytoReason operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is CytoReason based?
CytoReason is headquartered in Tel Aviv, Israel.